Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2014
02/06/2014US20140037625 Biomarkers and methods of treatment
02/06/2014US20140037624 Anti-fgfr4 antibodies and methods of use
02/06/2014US20140037622 Human papilloma virus as predictor of cancer prognosis
02/06/2014US20140037616 Immunoglobulin 1
02/06/2014US20140037615 Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignancies
02/06/2014US20140037551 Antibodies to human b7x for treatment of metastatic cancer
02/06/2014US20140037543 Anti-Pancreatic Cancer Antibodies
02/06/2014US20140037540 Compositions against cancer antigen liv-1 and uses thereof
02/05/2014EP2692861A1 Nucleic acid construct containing nucleic acid derived from genotype 1b hcv genome, hcv genome-replicating cells transfected with same, and method for producing infectious hcv particles
02/05/2014EP2692737A1 Fully human anti-vap-1 monoclonal antibodies
02/05/2014EP2692736A1 BSA-specific antibodies
02/05/2014EP2692733A1 Nucleic acids encoding soluble forms of CD83
02/05/2014EP2692732A1 Novel allergen from ragweed pollen and uses thereof
02/05/2014EP2692359A1 Potentiator of cancer immunity containing rankl antagonist
02/05/2014EP2692358A1 Therapeutic agent for cancer, and method for determining prognosis of cancer
02/05/2014EP2692357A1 Novel anti-plasmodium parasite antibodies
02/05/2014EP2691549A1 Natural derivate of the lactobacillus johnsonii strain cncm 1-1225 deficient in d-lactic acid production
02/05/2014EP2691422A2 Methods and compositions for cytomegalovirus il-10 protein
02/05/2014EP2691421A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
02/05/2014EP2691420A1 Modulators of plexin b2 activity
02/05/2014EP2691419A2 Antibodies directed against icos and uses thereof
02/05/2014EP2691113A1 Methods of administering beta7 integrin antagonists
02/05/2014EP2691112A1 Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments
02/05/2014EP2691111A1 Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications
02/05/2014EP2691110A1 Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells
02/05/2014CN103562389A A novel expression cassette for efficient surface display of antigenic proteins
02/05/2014CN103562388A Novel hypoallergens
02/05/2014CN103562381A Derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with an improved shelf life
02/05/2014CN103562226A Use of inhibitors of EGFR-family receptors in the treatment of hormone refractory breast cancers
02/05/2014CN103562224A Antibodies against human IL33R and uses thereof
02/05/2014CN103562223A Anti c-Met antibodies
02/05/2014CN103561771A Re-directed immunotherapy
02/05/2014CN103561765A Complement factor B analogs and their uses
02/05/2014CN103561764A Adjuvant composition containing citrulline
02/05/2014CN103561763A Immunogenic bordetella bronchiseptica compositions
02/05/2014CN103561762A Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus
02/05/2014CN103561761A Methods and compositions for improving antiangiogenic therapy with anti-integrins
02/05/2014CN103561760A Immunomodulatory compositions, methods and systems comprising immunogenic fragments of APOB100
02/05/2014CN103561759A Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the pi3k-akt mtor pathway
02/05/2014CN103561734A Synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
02/05/2014CN103561726A Novel compositions and uses of anti-hypertension agents for cancer therapy
02/05/2014CN103555766A Rabbit hemorrhagic disease virus-like particles as well as preparation method and application thereof
02/05/2014CN103555746A Recombinant porcine circovirus type 2 virus-like particle, and preparation method and application thereof
02/05/2014CN103555733A Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
02/05/2014CN103555726A Unmethylated CpG contained DNA sequence (CpG-DNA) and its application
02/05/2014CN103555680A PRRSV (porcine reproductive and respiratory syndrome virus) virus-like particles with immunogenicity as well as preparation and application thereof
02/05/2014CN103555669A 黄病毒疫苗 Flavivirus vaccines
02/05/2014CN103555645A Resistance marker-free attenuated live vaccine against porcine contagious pleuropneumonia (PCP) and application thereof
02/05/2014CN103554271A Conjugate of an antibody against CD4 and antifusogenic peptides
02/05/2014CN103554265A Solid-phase synthesis method for gonadotropin-releasing hormone (GnRH) castration vaccine
02/05/2014CN103554264A Bispecific antibody aiming at IL-1beta and IL-17A and application thereof
02/05/2014CN103554263A Apoptotic anti- IgE antibodies binding the membrane-bound IgE
02/05/2014CN103554262A Anti-cyclooxygenase humanized single-chain antibody
02/05/2014CN103554261A A CA6 antigen-specific cytotoxic conjugate and methods of using the same
02/05/2014CN103554254A Chicken egg yolk antibody resisting human A rotavirus as well as preparation method and application thereof
02/05/2014CN103554241A Recombinant protein ASPPR with immunoregulatory activity and application thereof
02/05/2014CN103554235A RBD (receptor binding domain) segment in MERS-CoV (Middle East respiratory syndrome coronavirus) membrane protein and coding gene and application thereof
02/05/2014CN103554228A GnRH (gonadotropin-releasing hormone) castrated vaccine as well as parallel body
02/05/2014CN103554227A Polypeptide and use thereof
02/05/2014CN103550790A Applications of Periostin gene and Periostin antibody in preparation of medicaments
02/05/2014CN103550789A Preparation and application of oral tumor vaccine with attenuated salmonella typhimurium as vector
02/05/2014CN103550780A Protein protective agent for Pasteur inactivating human intravenous immunoglobulin and inactivation method of protein protective agent
02/05/2014CN103550773A Multivalent combined vaccine
02/05/2014CN103550772A Production method of pseudorabies virus vaccine
02/05/2014CN103550771A Production method of transmissible gastroenteritis virus vaccine
02/05/2014CN103550770A Preparation method of compound effervescent tablets for treating chicken infectious bursal disease
02/05/2014CN103550769A Production method of porcine circovirus type 2
02/05/2014CN103550768A Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
02/05/2014CN103550767A Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
02/05/2014CN103550766A Production method of anti-helicobacter pylori (Hp) immune pasteurized milk
02/05/2014CN103550765A Streptococcus iniae DNA (Deoxyribonucleic Acid) vaccine as well as application thereof
02/05/2014CN103550764A Novel method and compositions
02/05/2014CN103550763A Nano vaccine of LAMP-2 epitope peptide and preparation method of nano vaccine
02/05/2014CN103550762A Novel vaccine distributing equipment and distributed-vaccine production method
02/05/2014CN103550400A Chinese medicinal composition capable of improving immunity of poultry as well as preparation and preparation method thereof
02/05/2014CN103550286A Effervescent tablet immunologic adjuvant for chicken infectious bursal disease live vaccine
02/05/2014CN103041383B Heatproof freeze-drying protective agent of live vaccine, live vaccine freeze-drying powder and preparation method thereof
02/05/2014CN102964432B Method for restraining phosphorylation of M1 protein of influenza virus A and applications of method
02/05/2014CN102949713B Bacillus subtilis multi-valent vector-based vaccine and application thereof
02/05/2014CN102816740B Avian influenza virus, inactivated vaccine and method for preparing same
02/05/2014CN102764433B Prawn white spot syndrome virus multivalent vector vaccine and application thereof
02/05/2014CN102618504B Bivalent vaccine for hemorrhagic fever with renal syndrome and its preparation method
02/05/2014CN102406931B Pandemic influenza virus split vaccine
02/05/2014CN102327609B Production method of encephalitis B vaccine
02/05/2014CN102206663B Nucleic acid construct containing full-length genome of human hepatitis C virus and uses
02/05/2014CN102178945B Preparation method of inactivated vaccine for iridovirus of grouper
02/05/2014CN102028947B Inhibitor, inhibitor composition and inhibiting method of FAM3B gene, fatty liver treatment method and pharmaceutical application of inhibitor
02/04/2014US8642742 Anti-CEA antibodies
02/04/2014US8642741 Human antibodies to human TNF-like ligand 1A (TL1A)
02/04/2014US8642731 Porphyromonas gingivalis polypeptides and nucleotides
02/04/2014US8642726 Peptide epitopes of apolipoprotein B
02/04/2014US8642651 Methods and compositions for improved chromium complexes
02/04/2014US8642565 Increase of immune response and targeting by antigens and/or drug linkage
02/04/2014US8642546 FGF21 mutant fusion polypeptides and uses thereof
02/04/2014US8642531 Influenza antigen delivery vectors and constructs
02/04/2014US8642357 Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis and alveolar destruction
02/04/2014US8642276 Method for the production of an immunostimulating mucin (MUC1)
02/04/2014US8642258 Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica
02/04/2014US8642257 Vaccinia virus for diagnosis and therapy of tumors
02/04/2014US8642050 Gonococcal proteins and nucleic acids
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 1823